Literature DB >> 22392103

Uric acid is an important predictor for hypertensive early atherosclerosis.

Ruya Mutluay1, Serpil Muge Deger, Eylem Bahadir, Alim Ozgur Durmaz, Riza Citil, Sukru Sindel.   

Abstract

INTRODUCTION: The association between hyperuricemia and cardiovascular disease in hypertensive subjects is controversial. Attempts to elucidate the possible association between hyperuricemia and early atherosclerosis in hypertensive patients may provide alternative prevention or therapy targets for future cardiovascular events.
METHODS: A total of 67 hypertensive and 30 healthy subjects underwent B-mode ultrasonography to measure carotid intima media thickness (C-IMT). All biochemical analyses were assessed by local laboratories using standard laboratory methods.
RESULTS: C-IMT, serum uric acid (UA) levels, and mean arterial blood pressure (MBP) levels were significantly higher in hypertensive population compared to healthy subjects (P<0.001). Among hypertensive subjects, high sensitivity C-reactive protein (hs-CRP), C-IMT, and proteinuria levels were significantly higher in hyperuricemic patients compared to normouricemic participants (for all, P<0.05). Age (r=0.28, P=0.02), MBP (r=0.34, P=0.04), hs-CRP (r=0.58, P=0.006), proteinuria (r=0.58, P=0.007), estimated glomerular filtration rate (r=-0.35, P=0.02), and UA (r=0.31, P=0.02) levels were significantly associated with C-IMT levels. Multiple linear regression analysis using C-IMT as a dependent variable showed that age (beta=0.84, P=0.03) and UA levels (beta=-0.87, P=0.02) were independently associated with C-IMT.
CONCLUSION: Hyperuricemia is an independent predictor for early atherosclerosis in hypertensive subjects with normal renal function. Therefore, the optimal control of UA may provide further benefits in preventing atherosclerosis and hypertensive end-organ injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392103     DOI: 10.1007/s12325-012-0006-z

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  10 in total

Review 1.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

2.  Association between high-sensitivity C-reactive protein and hyperuricemia.

Authors:  Tuo Yang; Xiang Ding; Yi-Lun Wang; Chao Zeng; Jie Wei; Hui Li; Yi-Lin Xiong; Shu-Guang Gao; Yu-Sheng Li; Guang-Hua Lei
Journal:  Rheumatol Int       Date:  2016-02-10       Impact factor: 2.631

Review 3.  Carotid intima-media thickness in patients with hyperuricemia: a systematic review and meta-analysis.

Authors:  Li-Hui Peng; Yue He; Wang-Dong Xu; Zi-Xia Zhao; Mao Liu; Xiao Luo; Cheng-Song He; Jie Chen
Journal:  Aging Clin Exp Res       Date:  2021-04-09       Impact factor: 3.636

4.  Risk factors for peripheral arterial disease in elderly patients with Type-2 diabetes mellitus: A clinical study.

Authors:  Zhang Shou; Yongcai Zhao; Yan Zhang; Shaoqing Li
Journal:  Pak J Med Sci       Date:  2020 Sep-Oct       Impact factor: 1.088

5.  A cross-sectional analysis of the relationship between uric acid and coronary atherosclerosis in patients with suspected coronary artery disease in China.

Authors:  Yujiao Sun; Xin Yu; Ying Zhi; Song Geng; Hua Li; Ting Liu; Ke Xu; Ling Chen; Chunwei Wu; Guoxian Qi
Journal:  BMC Cardiovasc Disord       Date:  2014-08-16       Impact factor: 2.298

6.  Higher Levels of High-Sensitivity C-Reactive Protein Is Positively Associated with the Incidence of Hyperuricemia in Chinese Population: A Report from the China Health and Retirement Longitudinal Study.

Authors:  Hui-Xu Dai; Zhi-Ying Zhao; Yang Xia; Qi-Jun Wu; Yu-Hong Zhao
Journal:  Mediators Inflamm       Date:  2020-05-20       Impact factor: 4.711

7.  Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial.

Authors:  Zhaohu Hao; Xiao Huang; Hailin Shao; Fengshi Tian
Journal:  Ther Clin Risk Manag       Date:  2018-12-11       Impact factor: 2.423

8.  Hyperuricemia Is Associated with Left Ventricular Dysfunction and Inappropriate Left Ventricular Mass in Chronic Kidney Disease.

Authors:  Tai-Hua Chiu; Pei-Yu Wu; Jiun-Chi Huang; Ho-Ming Su; Szu-Chia Chen; Jer-Ming Chang; Hung-Chun Chen
Journal:  Diagnostics (Basel)       Date:  2020-07-24

9.  The effects of hyperuricemia on endothelial cells are mediated via GLUT9 and the JAK2/STAT3 pathway.

Authors:  Qian Nie; Miaomiao Liu; Zhimei Zhang; Xuemei Zhang; Chao Wang; Guangyao Song
Journal:  Mol Biol Rep       Date:  2021-10-30       Impact factor: 2.316

Review 10.  Review of hyperuricemia as new marker for metabolic syndrome.

Authors:  Laura Billiet; Sarah Doaty; James D Katz; Manuel T Velasquez
Journal:  ISRN Rheumatol       Date:  2014-02-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.